Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $508.5100 (-1.98%) ($506.8300 - $523.6400) on Thu. Sep. 3, 2015. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 12.5% (three month average) | RSI | 33 | Latest Price | $508.5100(-1.98%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -1.1% a day on average for past five trading days. | Weekly Trend | REGN declines -4.7% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(66%) XLV(53%) XBI(50%) QQQ(43%) IWF(42%) | Factors Impacting REGN price | REGN will decline at least -6.25% in a week (0% probabilities). VIXM(-16%) TLT(-9%) UUP(-5%) SKYY(-4%) SHY(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -6.25% (StdDev 12.5%) | Hourly BBV | 0 () | Intraday Trend | -2.9% | | | |
|
Resistance Level | $543.21 | 5 Day Moving Average | $514.78(-1.22%) | 10 Day Moving Average | $517.65(-1.77%) | 20 Day Moving Average | $543.21(-6.39%) | To recent high | -14.2% | To recent low | 3.3% | Market Cap | $53.917b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |